IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2008.04.11, JP 2008104147
2008.09.26, JP 2008247713
2009.03.19, JP 2009068744
Andrew W Drake ET AL: "Biophysical Consideration for Development of Antibody-Based Therapeutics" In: "Biophysical Consideration for Development of Antibody-Based Therapeutics", 1 January 2012 (2012-01-01), XP055100977, pages 95-97, (B1)
YANG W-P ET AL: "CDR WALKING MUTAGENESIS FOR THE AFFINITY MATURATION OF A POTENT HUMAN ANTI-HIV-1 ANTIBODY INTO THE PICOMOLAR RANGE", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, vol. 254, 1 January 1995 (1995-01-01), pages 392-403, XP000199739, ISSN: 0022-2836, DOI: 10.1006/JMBI.1995.0626 (B1)
CASIM A SARKAR ET AL: "Rational cytokine design for increased lifetime and enhanced potency using pH-activated histidine switching", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 20, no. 9, 1 September 2002 (2002-09-01), pages 908-913, XP002657852, ISSN: 1087-0156, DOI: 10.1038/NBT725 [retrieved on 2002-08-05] (B1)
FREDERICK R MAXFIELD & TIMOTHY E MCGRAW: "Endocytic recycling", NATURE REVIEWS MOLECULAR CELL BIOLOGY, NATURE PUBLISHING, GB, vol. 5, no. 2, 1 February 2004 (2004-02-01), pages 121-132, XP009151548, ISSN: 1471-0072 (B1)
IGAWA T ET AL: "Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 28, no. 11, 1 November 2010 (2010-11-01), pages 1203-1207, XP009153598, ISSN: 1087-0156, DOI: 10.1038/NBT.1691 (B1)
IGAWA TOMOYUKI ET AL: "Engineering the variable region of therapeutic IgG antibodies", MABS, LANDES BIOSCIENCE, US, vol. 3, no. 3, 1 May 2011 (2011-05-01), pages 243-252, XP009153597, ISSN: 1942-0870 (B1)
ITO W ET AL: "The His-probe method: effects of histidine residues introduced into the complementary-determining regions of antibodies on antigen-antibody interactions at different pH values", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 309, no. 1, 1 August 1992 (1992-08-01), pages 85-88, XP008123385, ISSN: 0014-5793 (B1)
ITO, W. ET AL.: 'The His-probe method: effects of histidine residues introduced into the complementarity-determining regions of antibodies on antigen-antibody interactions at different pH values.' FEBS LETT. vol. 309, no. 1, 1992, pages 85 - 88, XP008123385 (B1)
LEE C V ET AL: "High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, vol. 340, no. 5, 23 July 2004 (2004-07-23) , pages 1073-1093, XP002716293, ISSN: 0022-2836, DOI: 10.1016/J.JMB.2004.05.051 (B1)
MAEDA K ET AL: "pH-dependent receptor/ligand dissociation as a determining factor for intracellular sorting of ligands for epidermal growth factor receptors in rat hepatocytes", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 82, no. 1, 18 July 2002 (2002-07-18), pages 71-82, XP004369791, ISSN: 0168-3659, DOI: 10.1016/S0168-3659(02)00126-8 (B1)
MARTIN, W.L. ET AL.: 'Crystal Structure at 2.8A of an FcRn/Heterodimeric Fc Complex: Mechanism of pH-Dependent Binding.' MOL.CELL. vol. 7, 2001, pages 867 - 877, XP003027710 (B1)
MEGAN L. MURTAUGH ET AL: "A combinatorial histidine scanning library approach to engineer highly pH-dependent protein switches", PROTEIN SCIENCE, vol. 20, no. 9, 1 September 2011 (2011-09-01), pages 1619-1631, XP055011183, ISSN: 0961-8368, DOI: 10.1002/pro.696 (B1)
RUDIKOFF S ET AL: "Single amino acid substitution altering antigen-binding specificity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 79, 1 March 1982 (1982-03-01), pages 1979-1983, XP007901436, ISSN: 0027-8424, DOI: 10.1073/PNAS.79.6.1979 (B1)
Rebecca L. Rich ET AL: "Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'", Journal of Molecular Recognition, vol. 23, no. 1, 16 January 2010 (2010-01-16), pages 1-64, XP55064620, ISSN: 0952-3499, DOI: 10.1002/jmr.1004 (B1)
T. IGAWA ET AL: "Reduced elimination of IgG antibodies by engineering the variable region", PROTEIN ENGINEERING DESIGN AND SELECTION, vol. 23, no. 5, 1 May 2010 (2010-05-01), pages 385-392, XP055003115, ISSN: 1741-0126, DOI: 10.1093/protein/gzq009 (B1)
TETSUO K ET AL: "A monoclonal antibody specific for a distinct region of hen egg-white lysozyme", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 19, no. 4, 1 April 1982 (1982-04-01), pages 619-630, XP023681027, ISSN: 0161-5890, DOI: 10.1016/0161-5890(82)90231-0 [retrieved on 1982-04-01] (B1)
US-A1- 2003 059 937 (B1)
WO-A1-2009/139822 (B1)
WO-A2-2011/111007 (B1)
Bassett ET AL: "STUDIES ON HUMAN ANTIBODIES. 3. AMINO ACID COMPOSITION OF FOUR ANTIBODIES FROM ONE INDIVIDUAL.", Journal of Experimental Medicine, vol. 122, 1 August 1965 (1965-08-01), pages 251-261, XP055057759, ISSN: 0022-1007 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
Patent opphevet | EP-patent opphevet etter innsigelse i EPO |
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende
Hovedbrev e-post
|
Utgående
EP defect letter
|
Utgående
EP Batch Varsel om betaling av første årsavgift (3319)
|
Innkommende
E-post
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 14. avg. år (EP) | 2022.04.06 | 4500 | ENVOY INTERNATIONAL LIMITED | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2021.04.08 | 4200 | ENVOY INTERNATIONAL LIMITED | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2020.04.07 | 3850 | ENVOY INTERNATIONAL LIMITED | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2019.04.11 | 3500 | ENVOY INTERNATIONAL LIMITED | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2018.04.23 | 3200 | ENVOY INTERNATIONAL LIMITED | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2017.04.27 | 2850 | ENVOY INTERNATIONAL LIMITED | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2016.04.22 | 2550 | DENNEMEYER CO S.A R.L. | Betalt og godkjent |
31603130 expand_more expand_less | 2016.03.07 | 5500 | Zacco Norway AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|